The EVAR Center

Filter Your Results




Suprarenal Fixation Is Safe, Effective, and Necessary

Roy K. Greenberg, MD

August 2005—Recent large, prospective, randomized trials have provided evidence justifying the treatment of aneurysms >5.5 cm in patients fit for open repair.1,2 Although questions rem…

Optimal EVAR Fixation: Rebuttals

Dieter Raithel, MD, PhD, et al

August 2005—In his article “Suprarenal Stenting,” Roy Greenberg, MD, strongly emphasized two key points—the necessity and safety of this technique. Regarding his section on “Neces…

Interview With Roger Greenhalgh, MD

Roger Greenhalgh, MD

August 2005—One of the world's pre-eminent vascular surgeons shares his viewpoints on the EVAR and DREAM trials and Charing Cross 2006.

An Interview With Roy K. Greenberg, MD

Roy K. Greenberg, MD

June 2005—How did your father and his work influence your path in medicine? My father's background is in architecture and engineering, and he was very analytical and processed as an en…

Percutaneous Endovascular AAA Repair

Niten Singh, MD; Eric Adams, MD; Richard Neville, MD; and David H. Deaton, MD

April 2005—Percutaneous EVAR can be performed with a high degree of success.

Impact of the EVAR-1 and DREAM Trials

Jan D. Blankensteijn, MD

March 2005—Is endovascular aneurysm repair better than open repair, or is the race still on?

Treating Smaller AAAs

Kenneth Ouriel, MD

March 2005—Does the availability of endovascular grafts change the size threshold for repair?

Treating Large/Complex Aneurysms

Roy K. Greenberg, MD

March 2005—Techniques and technologies involving branched or fenestrated devices have emerged to offer new EVAR options.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.